UBA appoints Chris Ofikulu as new MD/CEO

UBA appoints Chris Ofikulu as new MD/CEO

Published March 8, 20222 min read

0 views

Topics in this article

UBAChris OfikuluUBA appoints Chris Ofikulu as new MD/CEO

Comment guidelines

Please keep comments respectful. Use plain English for our global readership and avoid using phrasing that could be misinterpreted as offensive. By commenting, you agree to abide by our community guidelines and these terms and conditions. We encourage you to report inappropriate comments.

All Comments0

No comments yet. Be the first to share your thoughts.

Related Coverage: Banking & Finance

BoG urged to set minimum fraud controls for PSPs
Banking & Finance

BoG urged to set minimum fraud controls for PSPs

The Bank of Ghana (BoG) should introduce minimum fraud control standards specifically tailored for payment service providers (PSPs) to strengthen safeguards across the digital payments ecosystem, financial markets expert and University of Ghana Business School part-time lecturer Norman Adu Bamfo has said.

Ecobank  supports flood-affected communities
Banking & Finance

Ecobank  supports flood-affected communities

Ecobank Ghana has donated relief items valued at over GHS257,000 to support individuals and families in communities affected by the recent floods that impacted Accra and several other parts of the country.

FirstBank launches 4th edition of Junior Internship Programme
Banking & Finance

FirstBank launches 4th edition of Junior Internship Programme

FirstBank Ghana has officially launched the fourth edition of its flagship Junior Internship Programme (JIP) at its head office in Accra, reaffirming the Bank's commitment to developing financially responsible, confident and future-ready young people.

Bank of Ghana revokes Zeepay's DEMI licence over regulatory breaches
Banking & Finance

Bank of Ghana revokes Zeepay's DEMI licence over regulatory breaches

The Bank of Ghana (BoG) has revoked the Dedicated Electronic Money Issuer (DEMI) licence of Zeepay Ghana Ltd, effective July 14, 2026, citing multiple regulatory breaches and the company's persistent failure to comply with regulatory directives.